| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.1 | 1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |